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Abstract
Defining the most adequate architecture of a bone substitute 
scaffold is a topic that has received much attention over 
the last 40 years. However, contradictory results exist on 
the effect of grain size and microporosity. Therefore, the 
aim of this study was to determine the effect of these two 
factors on the in vivo behaviour of β-tricalcium phosphate 
(β-TCP) scaffolds. For that purpose, β-TCP scaffolds 
were produced with roughly the same macropore size 
(≈ 150 μm), and porosity (≈ 80 %), but two levels of 
microporosity (low: 10 % / high: ≈ 25 %) and grain size 
(small: 1.3 μm /large: ≈ 3.3 μm). The sample architecture 
was characterised extensively using materialography, Hg 
porosimetry, micro-computed tomography (μCT), and 
nitrogen adsorption. The scaffolds were implanted for 
2, 4 and 8 weeks in a cylindrical 5-wall cancellous bone 
defect in sheep. The histological, histomorphometrical and 
μCT analysis of the samples revealed that all four scaffold 
types were almost completely resorbed within 8 weeks and 
replaced by new bone. Despite the three-fold difference 
in microporosity and grain size, very few biological 
differences were observed. The only significant effect 
at p < 0.01 was a slightly faster resorption rate and soft 
tissue formation between 4 and 8 weeks of implantation 
when microporosity was increased. Past and present results 
suggest that the biological response of this particular defect 
is not very sensitive towards physico-chemical differences 
of resorbable bone graft substitutes. As bone formed not 
only in the macropores but also in the micropores, a closer 
study at the microscopic and localised effects is necessary.
Keywords: Resorption, bone graft, calcium phosphate, 
microstructure, porosity, scaffold, tricalcium phosphate, 
micropore, grain, size.
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Introduction
Synthetic bone graft substitutes (BGSs) have been 
increasingly used over the past 40 years as replacement 
for autologous bone grafts (Klawitter and Hulbert, 
1971; Hench, 2006). Intensive efforts have been made 
to determine the most adequate composition and 
architecture. On the chemical side, many materials varying 
in composition and architecture have been proposed, 
including polymers (Ishaug-Riley et al., 1997; Ignatius 
et al., 2001; Mondrinos et al., 2006; Gogolewski et al., 
2008), metals (Ayers et al., 1999; Bobyn et al., 1999; Itala 
et al., 2001; Witte et al., 2007) and ceramics (Klawitter 
and Hulbert, 1971; Klein et al., 1985; van Blitterswijk et 
al., 1986; Eggli et al., 1988; Daculsi and Passuti, 1990; 
Schliephake et al., 1991; Basle et al., 1993; Metsger et al., 
1993; Lu et al., 1999; Flautre et al., 2001; Walsh et al., 
2003; Jones and Hench, 2004; Linhart et al., 2004; Hench, 
2006; Von Doernberg et al., 2006; Mastrogiacomo et al., 
2007; Lan Levengood et al., 2010; Murakami et al., 2010; 
Yuan et al., 2010; Polak et al., 2011; Haugen et al., 2013). 
These materials present very different resorption rates, 
and many resorption mechanisms, such as dissolution, 
hydrolysis (e.g., poly(α-hydroxy acids) (Ignatius et al., 
2001)), cell-mediated resorption (Basle et al., 1993; Lu et 
al., 1999; Von Doernberg et al., 2006; Yuan et al., 2010), 
corrosion (Witte et al., 2007), enzymatic degradation 
(Hutmacher, 2000; Vert, 2007), and transport (Vert, 2007).
 Beside chemical effects, architectural aspects have also 
been considered to be crucial for the in vivo response. These 
include porosity (Klein et al., 1985; Metsger et al., 1993), 
pore size (Klawitter and Hulbert, 1971; van Blitterswijk 
et al., 1986; Eggli et al., 1988; Daculsi and Passuti, 1990; 
Schliephake et al., 1991; Metsger et al., 1993; Ayers et 
al., 1999; Itala et al., 2001; von Doernberg et al., 2006; 
Chan et al., 2012), interconnection pore size (Lu et al., 
1999; Flautre et al., 2001) or granule size (Malard et 
al., 1999; Murakami et al., 2010). Microscopic features 
such as micropores or crystal grain size have also been 
the subject of investigations (Klein et al., 1983; Klein 
et al., 1984; Klein et al., 1985; Klein et al., 1986; De 
Groot, 1988; De Groot et al., 1988; Van der Meulen and 
Koerten, 1994; Gauthier et al., 1999; Lan Levengood et 
al., 2010; Wei et al., 2010; Yuan et al., 2010; Campion et 
al., 2011; Chan et al., 2012; Coathup et al., 2012) (Table 
1). For example, Wei et al. (Wei et al., 2010) implanted 
magnesium-calcium phosphate macroporous scaffolds with 
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Table 1. List in alphabetical order of several studies devoted to the effect of architectural factors on the in vivo performance 
of resorbable calcium phosphate ceramic scaffolds (sintered hydroxyapatite is considered to be non-resorbable). Various 
aspects were considered: micro and macropore size, Micro and macroporosity, grain size, pore interconnection size. 
Abbreviations: d = days; w = weeks; m = months; NA = not applicable / no response; MPor = macroporosity; µPor = 
microporosity.
Author
Animal model
(Implantation time) Material Investigated factor(s) Resorption Bone formation Remarks
Bai et al. (Bai et 
al., 2010)
Rabbits
(1, 2, 4, 8 w)
β-TCP Macropore size and 
Interconnection size
MPor size: 300-400, 400-
500, 500-600, 600-700 μm; 
interconnection: from 72 to 
198 μm; porosity: 67-79 %
NA NA Increase of blood vessel ingrowth with an increase 
of macropore and interconnection size
Feng et al. (Feng 
et al., 2011)
Rabbits
(1, 2, 4, 8 w)
β-TCP Macropore size 
MPor size: 300-400, 400-
500, 500-600, 600-700 μm; 
interconnection ≈ 120 μm; 
porosity ≈ 72 %
NA NA Decrease of fibrous tissue ingrowth and increase of 
blood vessel ingrowth with an increase of macropore 
size
Eggli et al. (Eggli 
et al., 1988)
Rabbits
(2, 4 w, 4, 6 m)
β-TCP Macropore size
MPor size: group 1: 50-100, 
Group 2: 200-400 μm.
2/3 and 5/6 
resorbed after 
6 months for 
group I and II, 
resp.
≈ 2x faster in group I 
than group II at 2 and 
4 weeks
Very limited material characterization
Gauthier et al. 
(Gauthier et al., 
1999)
Rabbits
(8 w)
BCP Grain size
Two groups produced 
according to the same method 
but with two different raw 
materials
Fourfold 
increase of 
resorption 
rate with an 
increase of 
grain size
No difference No grain size measurement. Group 1: roughly 1 
μm grain size; Group 2: 0.1-0.2 μm grain size. Not 
the same raw material for the two groups. No 3D 
characterization of the architecture.
Hong et al. (Hong 
et al., 2010)
Dogs
(45, 90 d)
BCP Grain size
Two groups; Difference of 
grain size between group 1 
(86 ± 20 nm) and group 2 
(768 ± 321 nm)
NA 10-20 % more bone 
formation in group 1
Kasten et al. 
(Kasten et al., 
2008)
SCID Mice
(8 w)
β-TCP Porosity
Three groups with 25, 65 and 
75 % porosity
NA In vivo ALP activity 
highest with 65 % 
porosity, lowest with 
25 % porosity
“Higher porosity does not necessarily mean higher 
ALP activity in vivo”
Klein et al. (Klein 
et al., 1985)
Rabbits
(16 m)
β-TCP Microporosity and 
Macroporosity
Four groups without or with 
macropores, and with a small 
(< 5 %) and large (50-60 %) 
amount of micropores
Faster 
resorption 
of the 
microporous 
samples
More bone ingrowth 
in the macroporous 
samples
Only qualitative results. Only one histological time 
point (16 months). Only XRD to assess resorption 
within the first months of implantation
Klein et al. (Klein 
et al., 1983)
Rabbits
(3, 6, 9 m)
β-TCP Microporosity and 
Macroporosity
Group 1: MPor: 0 %; μPor: 
2 %; Group 2: MPor: 0 %; 
μPor: 40 %; Group 3: MPor: 
30 %; μPor: 2 %; Group 4: 
MPor: 30 %; μPor: 40 %;
Faster 
with more 
macroporosity 
and 
microporosity
NA Only qualitative results. De Groot mentioned a 
degradation rate at 3 months of 15 % and 30 % for 
groups 3 and 4 (De Groot, 1988). In vitro dissolution 
data in (Klein et al., 1984), in line with in vivo 
results.
Klein et al. (Klein 
et al., 1986)
Rabbits
(3, 6, 12 m)
β-TCP Microporosity and 
Macroporosity
5 groups; Microporosity 
between 40 and 55 %; 
Macroporosity between 0 
and 20 %.
Faster 
with more 
macroporosity 
and 
microporosity
No difference Only qualitative results.
Metsger (Metsger 
et al., 1993)
Turkeys
(2, 4, 6 m)
β-TCP Macroporosity and Porosity
“two pore size distributions 
and four pore densities”
Qualitatively, 
slightly faster 
resorption in 
smaller pores
Qualitatively, slightly 
faster bone ingrowth 
in smaller pores
Not clear how many materials were tested and how 
they differed
Observation of a coupling between resorption and 
bone formation
Okuda et al. 
(Okuda et al., 
2007)
Rabbits
(2, 4, 12, 24 w)
β-TCP Microstructure
Fiber-like and sintered-like 
structure. μPor size: 0.2 μm 
and 0.5 μm respectively. 
Porosity: 70 %
No difference 
within the first 
12 weeks
No difference within 
the first 12 weeks
Von Doernberg 
et al. (von 
Doernberg et al., 
2006)
Sheep
(6, 12, 24 w)
β-TCP Macropore size 
MPor size: 150, 260, 510, 
1220 μm; μPor ≈ 21 %; MPor 
≈ 54 %, Porosity ≈ 75 %
Almost no 
difference
No difference
Wei et al. (Wei et 
al., 2010)
Rabbits
(1, 2, 3, 6 m)
PHA1)
MAP2)
Macroporosity
Both materials produced 
without and with macropores. 
Porosity: 52-78 %. MPor size: 
400-500 μm.
NA More bone in the 
macroporous samples, 
but only at 3 and 6 
months implantation
Yokozeki et al. 
(Yokozeki et al., 
1998)
Rabbits
(4, 12, 24 w)
β-TCP Microporosity
Group 1: μPor ≈ NA; μPor 
size ≈ 0.2-0.5 μm; Porosity 
≈ 60 % ; MPor size: 150-
400 μm; SSA = 10 m2/g); 
Group 2: μPor ≈ 0 %; 
Porosity ≈ 57 % ; MPor size: 
150-400 μm; SSA = 2 m2/g
-30 % in 
ceramic area at 
24 w for group 
1; -2 % for 
group 2
No difference
Very small amount 
of bone
Not clear how a ceramic with 0 % microporosity 
can have a SSA value of 2 m2/g. No XRD data 
demonstrating that both ceramics are pure β-TCP. 
Not the same raw materials for the two groups.
9 and 27 % microporosity and observed that the presence of 
micropores increased the degradation rate and accelerated 
bone formation. A similar result was found by Yokozeki 
et al. (Yokozeki et al., 1998) and the group of De Groot 
(Klein et al., 1983; Klein et al., 1984; Klein et al., 1985; 
Klein et al., 1986; De Groot, 1988). Klein et al. (Klein et 
al., 1985) suggested that changes of microporosity degree 
played a more important role in the resorption process than 
changes in macroporosity degree. Lan Levengood et al. 
(Lan Levengood et al., 2010) stated that “the exploitation 
of microporosity to achieve multiscale osteointegration 
offers a new paradigm for scaffold design”. More 
recently, the presence of micropores was associated with 
the osteoinductive potential of calcium phosphate (CaP) 
ceramics (Yuan et al., 2010; Chan et al., 2012; Coathup 
et al., 2012), and a change in cell and bone ingrowth (Lan 
Levengood et al., 2010; Polak et al., 2013). Regarding grain 
size, grain boundaries were found to be attacked during 
resorption, leading to particle release (Van der Meulen and 
Koerten, 1994). Klein et al. mentioned that this localised 
dissolution controls resorption (Klein et al., 1984) and that 
the dimensions and composition of the grain boundary 
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(= neck) affect their resorption (Klein et al., 1986). Also, 
dissolution-precipitation reactions that are involved during 
calcium phosphate resorption (LeGeros, 1993; Koerten and 
van der Meulen, 1999; LeGeros, 2002; Le Nihouannen et 
al., 2005) were seen to occur between partly dissolved 
grains (Van der Meulen and Koerten, 1994). LeGeros et al. 
(LeGeros et al., 1988) and Klein et al. (Klein et al., 1983; 
Klein et al., 1986) observed an increase in resorption rate 
with a decrease in grain size.
 Even though most studies devoted to microscopic 
features suggest that an increase of microporosity and a 
decrease of grain size accelerate resorption, it is difficult 
to draw conclusions for two reasons. First, it is very 
difficult to vary one parameter (e.g., micropore size) 
without changing other parameters (e.g., porosity). As a 
result, most studies on the topic contain rather fragmentary 
microstructural characterisations. Second, contradictory 
results exist. For example, Gauthier et al. (Gauthier et al., 
1999) implanted biphasic CaPs and observed a fourfold 
decrease of degradation rate with an about fivefold decrease 
of grains / micropores. Therefore, the aim of the present 
study was to determine quantitatively the effect of a change 
of microporosity and grain size on the in vivo behaviour of 
β-TCP scaffolds. Compared to published studies, extensive 
investigations were performed prior to the study to design 
scaffolds varying independently in microporosity and grain 
size. Also in depth characterisations were performed to 
give a precise description of the four implanted scaffold 
types, in particular porosity, pore size (from the nano to the 
macroscale), and grain size. Finally, the 3D geometry was 
determined before and after implantation to eventually be 
able to apply a resorption model on the data (Bohner and 
Baumgart, 2004).
 In this article, nanopores were considered to be pores 
with diameters smaller than 100 nm. Micropores were 
defined as pores with diameters ranging between 100 nm 
and 50 μm. Finally, macropores were considered to have 
a diameter larger than 50 μm, as it is generally recognised 
that an interconnection size close to 50 µm is essential for 
bone ingrowth (Karageorgiou and Kaplan, 2005).
Materials and Methods
To investigate the effect of microporosity and grain 
size on the in vivo behaviour of β-TCP scaffolds, four 
types of macroporous β-TCP scaffolds were produced 
according to a 2 x 2 factorial design of experiment: (i) low 
microporosity and small grain size (denominated “mg”: 
“m” for a low microporosity and “g” for a small grain 
size), (ii) high microporosity and small grain size (“M” 
for high microporosity; “Mg”), (iii) low microporosity and 
large grain size (“G” for large grain size; “mG”), and (iv) 
high microporosity and large grain size (“MG”). For that 
purpose, two α-TCP powders, two blend compositions, and 
two sintering profiles were selected. The next paragraphs 
describe the synthesis procedure in more details.
Raw material synthesis
α-tricalcium phosphate (α-TCP; α-Ca3(PO4)2) was 
produced according to a procedure previously described 
(Bohner et al., 2009). The powder was then processed in 
two ways: (i) planetary milling (Pulverisette 5, Fritsch, 
Idar-Oberstein, Germany) for 2 h with 10 % fumaric acid 
(Lot #BCBB8136, Art 47910, Fluka/Sigma-Aldrich, St. 
Louis, MO, USA) and 2 mL ethanol (100 g α-TCP powder, 
500 mL jars, 100 ZrO2 beads (= 300 g)), followed by 
calcination at 500 °C for 12 h; this powder was used to 
produce mg and Mg samples; (ii) ball milling at 60 rpm 
for 6 h in ethanol (555 ± 5 g powder, 420 ± 4 g ethanol, 
5505 ± 10 g ZrO2 beads; 2L polyethylene (PE) bottles), 
drying in air and then calcination at 500 °C for 1 h and 
later on at 700 °C for 1 h; this powder was used to produce 
mG and MG samples.
Scaffold synthesis
All scaffolds were produced by isostatically pressing a 
mixture of α-TCP powder, stearic acid (Merck, Darmstadt, 
Germany; 1.00661.9020), and polyethylene glycol 
(PEG) spherical particles (Carbowax, Dow Chemical, 
Midland, MI, USA) at 200 MPa. The ratio between 
α-TCP powder and PEG particles was set at 0.70 g/g. To 
produce microporous samples (Mg and MG), wheat flour 
(Coop, Switzerland, www.coop.ch; d50 = 76 μm; bimodal 
distribution with peaks close to 30 μm and 100 μm) was 
added to these mixtures at a ratio of 1 g flour for 2 g PEG 
particles. Once isostatically pressed, various procedures 
were followed to achieve different microporosities and 
grain sizes: (i) mg samples: the samples were sintered 
1 h at 1000 °C, cut into 12 x 12 x 45 mm prisms, and 
machined into Ø = 8 mm x L = 13 mm cylinders; (ii) 
Mg samples: the pressed samples were machined into 
Ø = 8.35 mm x L = 13.50 mm cylinders, and sintered 1 h 
at 1000 °C; (iii) mG samples: the pressed samples were 
machined into Ø = 8.31 mm x L = 13.45 mm cylinders, 
and sintered 1 h at 1300 °C followed by 24 h at 900 °C; 
(iv) MG samples: the pressed samples were machined 
into Ø = 8.60 mm x L = 13.65 mm cylinders, and sintered 
1 h at 1300 °C followed by 24 h at 900 °C. Once all 4 
sample types were prepared, all samples were cleaned in 
ethanol, and calcined 1 h at 900 ºC. As the mG samples 
still contained large amounts of α-TCP after this calcination 
step, these samples were calcined once again at 900 °C for 
12 h. The samples were then inserted into 1.5 mL micro-
centrifuge tubes (4182.1, Carl Roth, Karlsruhe, Germany), 
packaged once in a peel (Stericlin®) and sterilised by 
γ-irradiation with a 25 kGy dose (Synergy Health, Däniken, 
Switzerland).
Scaffold characterisation
Various methods were used to characterise the physical and 
chemical properties of the four tested scaffolds: size and 
weight measurements, specific surface area measurements 
(SSA), materialography, scanning electron microscopy 
(SEM), micro-computed tomography (μCT), Mercury 
(Hg) porosimetry, x-ray diffraction (XRD). More details 
are provided hereafter.
Geometrical density and porosity
To determine the geometrical density and porosity, three 
samples per group were measured with a caliper gauge 
and weighed. The geometrical density, also called apparent 
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density, was always reported to β-TCP theoretical density 
(3.07 g/cc) to calculate the relative density and infer the 
porosity.
Specific surface areas
The SSA values were determined by N2 adsorption at 
77 K (Gemini 2360, Micromeritics, Norcross, GA, USA) 
applying the Brunauer-Emmett-Teller (BET) model with 
5 point determination. Three samples per group were dried 
several hours at 130 °C under constant N2 flow.
XRD
The crystalline composition of the scaffolds was assessed 
by XRD using a powder diffractometer (X’Pert Pro 
MPD, PANalytical, Netherlands) with Ni-filtered CuKα 
radiation in the range from 5-60° 2θ. The quantitative phase 
composition was determined by Rietveld refinement using 
the software Fullprof.2k (http://www.ill.eu/sites/fullprof/) 
version 5.00 (Rodriguez-Carvajal, 2001). Structural models 
were taken from Mathew et al. (Mathew et al., 1977) for 
α-TCP, from Schroeder et al. (Schroeder et al., 1977) for 
β-TCP and from Sudarsanan et al. (Sudarsanan and Young, 
1969) for hydroxyapatite (HA; Ca5(PO4)3). No other phases 
were identified in the diffraction patterns.
Materialography
Materialography was used to determine porosity, 
micropore diameter, and grain size. For that purpose, three 
samples per group were embedded in a resin (EpoFix, 
Struers, Birmensdorf, Switzerland). The samples were 
then polished (final polishing step with a water free 
0.2 µm silica suspension from Akasel) and observed by 
SEM using backscattered electrons. Image analysis was 
used to quantify the total porosity (number of pixels 
under and above an optically set threshold value of grey 
tones), the macroporosity (fraction of grid points falling 
on a macropore), and the porosity within the microporous 
regions. Additionally, the micropore size and the grain size 
distributions were estimated using a distance mapping/
fuzzy distance algorithm (Bashoor-Zadeh et al., 2011). 
Centreline skeletons passing through the maxima of the 
distance maps of void and grain structures, respectively, 
were used to determine the average sizes. For each pixel of 
the skeleton, the maximum circle that could be inscribed 
locally to fit the structure was determined and its diameter 
was registered. This process was repeated for each pixel 
of the skeleton of the void and grain spaces, respectively, 
hence resulting into a size distribution. The average sizes 
of both the void and grain structures were calculated by 
averaging the diameter circles registered.
Scanning electron microscropy
SEM examinations were performed with an EVO MA25 
microscope (Zeiss, Oberkochen, Germany). Prior to their 
examination, all samples were carbon coated twice.
Micro-computed tomography
μCT imaging was performed on a μCT 50 scanner (Scanco 
Medical, Brüttisellen, Switzerland). Scaffolds were 
scanned with an isotropic nominal resolution of 10 µm 
before in vivo implantation in a dry state (final cleaning and 
sterilisation were performed after μCT scanning) and after 
implantation, in 70 % ethanol (explants comprising the 
scaffold and part of the surrounding bone). Energy was set 
to 55 kV, intensity to 145 µA, integration time was 200 ms 
and a 2-fold frame averaging was used. A constrained 
Gaussian filter was applied to the resulting images using 
a filter width of 0.8 and filter support of 1. Morphological 
parameters of the scaffolds before implantation were 
evaluated on a smaller cylinder with 4 mm diameter and 
6.5 mm height from the middle of the scaffold to avoid 
influence of the surface. Threshold for segmentation was 
chosen individually per material and was 330 mg HA/ccm 
for Mg and 440 mg HA/ccm for mg, mG and MG. Scaffold 
volume density (BV/TV), macroporosity, connectivity 
density and pore size distribution was evaluated with the 
same analysis as used for human bone biopsy (Hildebrand 
et al., 1999).
 Samples after implantation were measured with the 
same settings. Some samples were damaged during 
operation procedure and excluded from the quantitative 
analysis. Images post-implantation were scaled to 20 µm 
resolution and orientated along the defect axis before 
Gaussian filtration. An iterative threshold algorithm was 
applied which automatically determined a threshold based 
on the histogram. Iterative thresholds varied for samples 
mg between 432 and 555 mg HA/cc, for samples Mg 
between 415 and 567 mg HA/cc, for samples mG between 
441 and 535 mg HA/cc and for samples MG between 415 
and 533 mg HA/cc. Three different regions of interests 
(ROI) were analysed per sample by applying cylindrical 
masks of different sizes. Cylinder diameter was kept to the 
original defect diameter of 8 mm, height varied between 
2 mm, 4 mm and 6 mm. The mask was placed for all 
samples on the bottom of the drill hole at the location 
where the maximum bore was reached. BV/TV inside 
the cylinders was assessed, which represents remaining 
scaffold and newly formed bone (contrary to a past study 
(Von Doernberg et al., 2006), in the present study it was 
not possible to distinguish bone from the scaffold).
Hg porosimetry
Hg porosimetry measurements were performed with a 
Pascal 140/440 porosimeter (Thermo Fisher Scientific, 
Reinach, Switzerland) with the aim to determine the size 
of open pores in the range between 7 nm and 100 μm using 
the Washburn equation. Surface tension and contact angle 
of mercury were set to 0.480 N/m and 140°, respectively 
and pressure was applied up to 200 MPa. Three samples 
from each group were dried overnight at 130 °C in order to 
drive off any adsorbed water from the sample. Multi-cycle 
porosimetry was performed to determine the neck size 
connected to the ink-bottle pores (pores that are connected 
to the outer part of the scaffold only through narrow pores) 
(Van Garderen et al., 2012).
Implantation procedure
The animal experiments were conducted according the 
Swiss law of animal welfare and protection and were 
granted by the local authorities (Kantonales Veterinäramt: 
authorisation # 199/2010). Eighteen female 3-year old 
Swiss Alpine sheep (63-77 kg body weight (bw.)) served as 
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experimental animals. A well-established drill-hole model 
in sheep was used to study the effect of microporosity and 
grain size on resorption behaviour and new bone formation 
(Nuss et al., 2006). Briefly, 8 mm drill holes in diameter 
and 14 mm in depth were drilled in the proximal and 
distal epiphyses of the humerus and femur. After flushing 
and cleansing the holes were filled randomly with the 
implants matching in size. Care was taken not to damage 
the edges of the ceramics during implantation. For this 
the implants were inserted through a drill guide of the 
same size held directly above the edges of the drill hole 
and gently pushing the implants with a flat insert into the 
drill hole. Eight materials were implanted per sheep, and 6 
sheep were taken per implantation time (2, 4 and 8 weeks), 
leading to a total of 144 samples. Here, only the results of 
the four materials varying in microporosity and grain size 
are presented in details (4 materials x 3 time points x 6 
repeats = 72 samples). This decision is supported by the 
fact that four of the eight calcium phosphate materials did 
not address the aim of the present study. Also, presenting 
the complete dataset would extend the study quite markedly 
without changing the conclusion.
 All surgeries were performed under general inhalation 
anaesthesia, and after recovery the sheep were allowed 
to roam free in stalls under appropriate antibiotic and 
analgesia regimen (benzylpenicillin 35000 IE/kg bw.; 
gentamicin sulphate 4 mg/kg bw.; buprenorphine 
0.001 mg/kg bw.; carprofen 4 mg/kg bw. for 3 days).
 Implants were retrieved after slaughtering of the 
animals by cutting bone blocks containing the original 
size of the ceramics and a safety margin of minimally 
4 mm at each side. The position of the original marker 
to indicate the location was respected and identified 
as good as possible before processing the samples for 
histology of non-decalcified bone blocks (Engelhardt and 
Gasser, 1995; Von Doernberg et al., 2006). Briefly, bone 
samples were fixed in 40 % ethanol and then dehydrated 
in a series of ethanol solutions (40-100 %) before being 
defatted in xylene. Importantly, μCTs of all samples were 
performed in the middle of the dehydration process, when 
samples were fixed in 70 % ethanol. Infiltration with 
polymethylmethacrylate was done under vacuum at 4 °C 
and final polymerisation at room temperature. Ground 
sections were prepared using a precision saw (Leica SP 
1600, Leica Microsystems, Nussloch, Germany) and 
cutting blocks transversely at a 90° angle to the insertion 
axis and at two levels (A and B). Sections were surface 
stained with toluidine blue. Toluidine blue selectively 
stains acidic tissue components (sulphates, carboxylates, 
and phosphate radicals), in particular polyanions (e.g., 
cartilage matrix, bone) (Sridharan and Shankar, 2012). 
Additionally, two thin sections (5 μm) were cut with 
a Microtome (Leica RM2155, Leica Microsystems, 
Wetzlar, Germany), placed on a sample holder coated with 
chromium gelatin, covered with a Kisol foil, dried for two 
days at 42 °C, and finally stained with either van Kossa/
McNeal or toluidine blue. The latter sections were used to 
assess the cell response.
 Evaluation of histological samples was conducted 
qualitatively and also quantitatively using for the latter 
a customised software program (Leica Quips/Qwin, 
Leica Microsystems). Percentage of newly formed bone, 
remaining ceramic and granulation tissue was calculated 
by two independent reviewers, and results were compared 
between groups. This quantification was done in three 
concentric rings (outer ring, middle ring, inner ring) (Von 
Doernberg et al., 2006). The cell response was assessed 
semi-quantitatively on the thin histological sections. For 
that purpose, cells were counted in four areas of the defect 
filled with the ceramic. The areas (zones 1 to 4) were spread 
equidistantly between the defect borders and the centre of 
the defect. Four groups were considered: (i) osteoclasts 
(defined arbitrarily here as multinucleated giant cells lying 
on a bone surface), (ii) multinucleated giant cells (defined 
arbitrarily here as multinucleated giant cells lying on a 
ceramic or sitting away from a surface), (iii) macrophages, 
and (iv) lymphocytes and plasma cells.
Statistics
Statistical analysis of the μCT and histology results was 
performed with PASW Statistics 18 (SPSS Inc., Chicago, 
IL, USA) using a univariate ANOVA and Bonferroni 
Post-Hoc test. The results were also analysed using a 
three-way factorial design of experiments (parameters: 
grain size, microporosity, implantation time). Significance 
was considered to occur for p < 0.05.
Results
Scaffold characterisation
Composition
The Rietveld refinement analysis of the XRD results 
revealed that three of the four scaffold types contained 
almost 100 % of β-TCP (Table 2). The group mG contained 
16 % α-TCP despite an additional thermal treatment at 
900 °C for 24 h. All materials were well crystallised as 
indicated by the very narrow diffraction peaks and the 
absence of broad and high baseline.
SEM
Great care was taken to characterise the scaffold 
architecture. Various methods were used including SEM, 
geometrical density, materialography, Hg porosimetry and 
μCT. The next paragraphs will describe the results obtained 
with these methods.
 No clear architectural differences could be detected by 
SEM at the macro level (Fig. 1). The macropores were fairly 
spherical and in a similar size range, close to 0.1-0.3 mm. 
However, the space between the macropores appeared 
to be looser or more porous going from sample mg to 
samples mG, Mg and MG. At a higher enlargement, much 
larger differences could be seen (Fig. 2). For example, mg 
samples presented a much finer and denser microstructure 
than MG samples. In fact, grain size, pore size, and porosity 
seemed to increase in the order mg, Mg, mG and MG. 
Interestingly, the group with a low microporosity and small 
grains (mg) presented a heterogeneous microstructure: 
dense zones as large as 10 µm in size were surrounded by 
sub-µm-sized solid particles.
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Geometrical density
According to the geometrical density results obtained, by 
weighing and size determination, the porosity did not vary 
much between the different scaffold types (Table 2). The 
values ranged between 78.3 ± 0.4 % and 83.8 ± 0.5 %. 
Significantly, higher values were found for the two 
microporous samples (83.8 ± 0.5 % and 81.2 ± 0.7 %, 
against 78.3 ± 0.4 % and 78.6 ± 0.5 %).
Materialography
The porosities measured by materialography were roughly 
3 % lower than those measured by weighing but were 
consistent with them (Table 2). Whereas the porosities 
varied within a relatively short range (75 ± 4 % to 
83 ± 1 %), larger changes were seen among macroporosities 
(from 48 ± 7 % to 65 ± 5 %) and microporosities (from 
10 ± 9 % (mg) to 30 ± 8 % (MG)). The difference was 
even larger when looking at the porosities within the 
microporous regions. Here, the values varied between 
21 ± 3 % (mg) and 56 ± 5 % (MG).
 Image analysis allowed the determination of the 
micropore size and grain size (Table 3; Fig. 3; Fig. 4). 
The micropore size varied significantly between all 
samples, going from mean values of 0.47 ± 0.02 μm 
Fig. 1. SEM microstructures of the 4 tested materials: (mg) small microporosity, small grains; (Mg) large microporosity, 
small grains; (mG) small microporosity, large grains; (MG) large microporosity, large grains. The scale bar corresponds 
to 200 µm. The pores are black and the material is white.
Table 2. Crystalline purity, porosity, macroporosity (“MPor”; pores larger than 50 μm), and microporosity (“μPor”) 
of the four scaffold types used in the animal study as determined by Rietveld refinement of XRD data, weighing, 
Materialography, Hg Porosimetry, and μCT. The results are reported as “mean ± one standard deviation”.
Weighing Materialography Hg Porosimetry μCT
Scaffold
XRD purity
[%]
Porosity
[%]
Porosity
[%]
MPor
[%]
μPor
[%]
Porosity
[%]
MPor
[%]
μPor4)
[%]
Porosity
[%]
MPor
[%]
μPor
[%]
mg 99 ± 1 78.3 ± 0.4 75 ± 4 65 ± 5 21 ± 31)
10 ± 92)
75.0 ± 1.0
72.0 ± 1.43)
11 ± 3 64 ± 4 56 ± 1 54 ± 2 2.5 ± 0.5
Mg 100 ± 1 83.8 ± 0.5 83 ± 1 61 ± 4 42 ± 111)
22 ± 52)
82.8 ± 0.7
76.4 ± 0.73)
22 ± 10 61 ± 11 58 ± 2 50 ± 3 7.6 ± 0.4
mG 84 ± 15) 78.6 ± 0.5 75 ± 3 65 ± 4 26 ± 11)
10 ± 72)
76.5 ± 0.1
73.8 ± 0.53)
47 ± 3 30 ± 3 59 ± 1 56 ± 2 3.1 ± 0.1
MG 100 ± 1 81.2 ± 0.7 78 ± 1 48 ± 7 56 ± 51)
30 ± 82)
77.9 ± 0.2
69.7 ± 2.63)
46 ± 1 32 ± 1 57 ± 3 50 ± 3 7.1 ± 0.2
1)Porosity in the microporous regions; 2)Difference between porosity and macroporosity; 3)Ink-bottle porosity; 4)
Difference between porosity and macroporosity: 5)The remaining 16 % consist of α-TCP.
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(mg) to 3.24 ± 0.09 μm (MG). These differences can be 
clearly identified on the cumulative pore size distributions 
(fraction of the pores smaller than a given value; Fig 
4a). The two “large grain” groups (mG and MG) had 
significantly larger grain sizes (3.11 ± 0.05 μm and 
3.43 ± 0.32 μm, respectively) than the two “small grain 
groups (1.27 ± 0.09 μm for mg and 1.29 ± 0.04 μm for Mg; 
Table 3; Fig 3; Fig. 4). However, no significant difference 
was noticed within the “large grain” and the “small grain” 
groups. This similarity can be better assessed on the grain 
size distribution curves (Fig. 3b; Fig. 4b).
Hg porosimetry
The porosities determined by Hg porosimetry were very 
similar to those measured by weighing and materialography. 
The values ranged between 75.0 ± 0.1 % and 82.8 ± 0.7 % 
(Table 2). A large fraction of the pores consisted of pores 
smaller than 50 μm (= micropores). For example, sample 
Fig. 2. SEM microstructures of the 4 tested materials: (mg) small microporosity, small grains; (Mg) large microporosity, 
small grains; (mG) small microporosity, large grains; (MG) large microporosity, large grains. The scale bar corresponds 
to 10 µm. The pores are black and the material is white.
Table 3. Mean micropore diameter (“Mean μPor Ø”), mean grain diameter, mean pore diameter, and specific 
surface area (SSA) of the four scaffold types used in the animal study as determined by XRD, Materialography, 
Hg Porosimetry, μCT, and N2 adsorption. The results are reported as “mean ± one standard deviation”. The mean 
micropore size determined by materialography was based on representative images of microporous areas. It is the 
volume-based mean value.
1)Number-based.
2)This value was calculated by considering that the pores were cylindrical (mean pore = 4 x pore volume / pore 
surface area).
3)Volume-based.
Materialography Hg Porosimetry μCT N2 adsorption
Scaffold
Mean μPor Ø1)
[µm]
Mean grain Ø1)
[µm]
Mean pore Ø2,3)
[µm]
Mean pore Ø3)
[µm]
Connectivity
[mm-3]
SSA
[m2/g]
mg 0.47 ± 0.02 1.27 ± 0.09 2.8 ± 1.0 169 ± 10 406 ± 94 0.79 ± 0.08
Mg 0.89 ± 0.11 1.29 ± 0.04 6.4 ± 3.7 153 ± 3 880 ± 29 0.64 ± 0.03
mG 1.44 ± 0.10 3.11 ± 0.05 15.7 ± 9.9 156 ± 3 520 ± 9 0.61 ± 0.02
MG 3.24 ± 0.09 3.43 ± 0.32 8.3 ± 1.5 122 ± 2 935 ± 45 0.37 ± 0.02
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Fig. 3. (a) Micropore size distribution (in number) as measured by image analysis of materialography images; (b) Grain 
size distribution (in number) as measured by image analysis of materialography images; (c) Pore size distribution (in 
volume) as measured by Hg porosimetry; (d) Pore size distribution (in volume) as measured by μCT. The total surface 
below the curves shown in (a), (b) and (c) is not constant because the number of intervals considered for each curve 
varies. For example, the mg and mG grain size curves contained 147 and 37 data points, respectively.
Fig. 4. (a) Cumulative micropore size distribution as measured by image analysis of materialography images; (b) 
Cumulative grain size distribution as measured by image analysis of materialography images; (c) Cumulative pore size 
distribution as measured by Hg porosimetry; (d) Cumulative pore size distribution as measured by μCT.
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Mg contained 61 ± 11 % microporosity (total porosity: 
82.8 ± 0.7 %). However, a thorough analysis of the pore 
size distribution using a multicycle analysis revealed that 
most of the porosity consisted of ink-bottle porosity, i.e., 
pores connected to the outer part of the scaffold by thin 
pores/necks. Once filled with Hg, these pores could not 
be emptied during depressurisation. Quantitatively, the 
difference between “porosity” and “ink-bottle porosity” 
varied between 76.5-73.8 = 2.7 % (sample mG) and 77.9-
69.7 = 8.2 % (sample MG) (see Table 2).
 The Hg porosimetry results also revealed clear 
differences of pore size distributions between the different 
groups. The two groups with large grains (groups mG 
and MG) contained bigger pores than those with small 
grains (groups mg and Mg; Table 2; Fig. 3c; Fig. 4c). 
This difference was particularly clear when looking at the 
diameter corresponding to a 50 % volume fraction (Fig. 
4c). Interestingly, the two samples containing flour (Mg 
and MG) had the highest volume fraction of pores smaller 
than 20 μm (Fig. 4c).
μCT results prior to implantation
Scaffolds were scanned and evaluated regarding 
morphological parameters by means of μCT before 
implantation. The scaffold structure was clearly different 
between high (Mg and MG) and low (mg and mG) 
microporosity, with a stable round pore shape and more 
material between the pores for the low microporosity 
samples (Fig. 5). The influence of grain size was not visible 
on the μCT cross-sectional images.
 Quantitatively, the porosity values measured by μCT 
were much lower than those measured by weighing and 
Fig. 5. Cross-sectional view of representative scaffolds before implantation imaged with μCT. The four groups are: 
(mg) small microporosity, small grains, (Mg) large microporosity, small grains, (mG) small microporosity, large 
grains, (MG) large microporosity, large grains. Scale bar is 1 mm.
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materialography: instead of being close to 80 %, the 
values were slightly below 60 % (56 ± 1 % to 59 ± 1 %; 
Table 2). Most of the porosity resulted from the presence 
of pores larger than 50 μm. As a result, the microporosity 
(pores smaller than 50 μm) determined by μCT remained 
low (from 2.5 % ± 0.5 % (mg) to 7.6 ± 0.4 % (Mg)). Even 
though the microporosity values determined by μCT were 
much lower than those measured by materialography, they 
showed the same trend: samples supposed to have a high 
microporosity (Mg: 7.6 ± 0.4 %; MG: 7.1 ± 0.2 %) were 
significantly more microporous than samples supposed 
to have a low microporosity (mg: 2.5 ± 0.5 %; mG: 
3.1 ± 0.1 %).
 All pore size distributions presented two peaks, one 
below 100 µm and the second one close to 200 µm, slightly 
shifted depending on the material (Fig. 3d). The latter peak 
was the largest for all samples but MG. On the cumulative 
plot (Fig. 4d), the curve for MG sample was markedly 
Fig. 6. representative histological (grinding) sections of the 4 tested materials at the three implantation times (2, 4 
and 8 weeks). The scale bars correspond to a size of 1 mm.
Fig. 7. representative histological (grinding) sections of the 4 tested materials showing the interdigitation between 
bone and ceramic. The sections are stained with toluidine blue. Bone appears in blue whereas the ceramic is whitish 
/ translucent. For each material, two images are shown, one with a moderate enlargement (200 x; scale bar: 100 μm; 
left image) and one with a higher enlargement (1000 x; scale bar: 20 μm; right image).
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higher than all other curves. This was mainly due to a steep 
increase of the curve up to a pore diameter of 100 μm.
 The density of pore interconnections was expressed by 
the mean connectivity density (Table 3). This value varied 
between 406 ± 94 mm-3 for mg group and 935 ± 45 mm-3 for 
MG group. Whereas the effect of grain size was moderate 
(+ 85 mm-3 on average between small and large grain size 
groups), the effect of microporosity was extensive (+ 445 
mm-3 on average).
SSA values
The SSA values were significantly higher for the two 
groups with the smallest grain sizes: 0.79 ± 0.08 m2/g and 
0.64 ± 0.03 m2/g for mg and Mg group respectively, against 
0.61 ± 0.02 m2/g and 0.37 ± 0.02 m2/g for mG and MG 
groups, respectively (Table 3). Whereas the latter result 
was expected, the significant decrease of the SSA values 
with an increase of microporosity was unexpected. The 
decrease was -0.13 m2/g and -0.24 m2/g for small and large 
grains, respectively.
Animal experiments
Implantation of ceramic scaffolds went well and all 
animals recovered without problems from surgery. No 
postoperative complications occurred and all specimens 
could be harvested after sacrifice of the animals. However, 
problems were encountered to locate the samples after 
implantation so several samples were damaged (cut) during 
Fig. 8. Histomorphometrical evolution of (a) ceramic, (b) bone and (c) soft tissue content upon implantation for the 
4 implanted ceramics. Correlation between ceramic and bone fraction (d). The three different symbol colours are 
used to distinguish the three different implantation times (blue: 8 weeks; red: 4 weeks; white: 2 weeks). The ceramic 
fraction of highly microporous samples was significantly lower at 4 and 8 weeks implantation than that of samples 
with lower microporosity (Fig 7a; “*”).
Fig. 9. Representative histological observations at the cellular level: (a) macrophages filled with ceramic residues 
(three macrophages are shown with an arrow); (b) multinucleated giant cell (arrow) sitting on a piece of ceramic 
(black colour); (c) osteoblast layer along an osteoid tissue sitting on a piece of ceramic.
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the retrieval procedure (e.g., Fig. 6e, Fig. 6h, Fig. 6j). Also, 
toluidine blue did not stain all sections homogeneously 
(e.g., Fig. 6h), rendering image analysis difficult.
 Qualitative evaluation of histology sections did not 
reveal major differences between the four scaffold types 
(Figs. 6 and 7). In all samples, ceramic resorption and 
bone replacement occurred from the periphery to the 
centre (Fig. 6). Generally, new bone was found in the outer 
regions of the early specimens (2 weeks) and granulation 
tissue in the inner regions, whereas already at 4 weeks 
small mineralisation nests and at 8 weeks new bone were 
found also within the inner regions. Overall, the picture 
was similar in all scaffold types with only few differences 
between them. At 8 weeks all groups showed trabecular 
bone and few remaining scaffold material, although it 
appeared that the mg group showed the densest and most 
regular trabecular bone structure compared to the other 
three groups. Also, low microporosity samples (mg and 
mG groups) seemed to show a more intact structure at the 
early time point of 2 weeks compared to those with a high 
microporosity. On the other hand, no obvious effect of 
grain size was noticed. In all four scaffold types, a tissue 
stained in blue was found within the microporous regions 
(Fig. 7). This blue stained tissue is called “bone” further 
in this document.
 Problems occurred with the quantitative evaluation 
especially in the early specimens (2 weeks). Since bone 
often formed within the ceramic micropores it was not 
possible to distinguish by computer technology the various 
fractions of new bone and remaining scaffold material 
(Fig 7). Therefore, semi-quantitative evaluation was also 
performed where the eye of the observers could more easily 
distinguish between the various fractions.
 The ceramic fraction decreased whereas the bone 
fraction increased from 2 to 8 weeks implantation (Fig. 8a, 
b). Since the two processes occurred almost simultaneously 
and to the same extent, the soft tissue fraction remained 
fairly constant throughout the whole implantation period 
(Fig. 8c) and a negative correlation was found between 
ceramic and bone fraction (Fig. 8d). Among all results, 
there were only two significant effects: the ceramic fraction 
of highly microporous samples was significantly lower at 4 
and 8 weeks implantation than that of samples with lower 
microporosity (p < 0.01). Simultaneously, there was more 
soft tissue in highly microporous samples (p < 0.01). In 
other words, the qualitatively superior behaviour of mg 
and to a smaller extent mG was supported statistically by 
histomorphometry.
 Some variations were observed between sheep at 
all time-points. For example, the mean ceramic fraction 
measured in one sheep varied in the range of 27-43 % 
at 2 weeks, 19-29 % at 4 weeks, and 6-18 % at 8 weeks. 
Smaller differences were observed for the bone fraction: 
4-8 % at 2 weeks, 17-25 % at 4 weeks, and 35-44 % at 8 
weeks. To increase the sensitivity of our analysis, results 
within a sheep were normalised relative to the mean, and 
the statistical analysis was performed again. However, the 
conclusions were the same as those without normalisation.
 No statistical difference of the cell response was found 
between the four scaffold types (Table 4). Generally, the 
number of cells varied radially from the outer zone (Z1) 
to the inner zone (Z4) over time. So, at early time, most 
cells were found in the outer zone. At later time points, 
most cells were found in the central area. The ceramic was 
partly resorbed by macrophages and multinucleated giant 
cells (Fig. 9).
μCT results post implantation
Parallel to the histomorphometry results, the in vivo samples 
were also analysed by μCT to evaluate quantitatively the 
evolution of ceramic and bone content after implantation. 
Regions of interest (ROIs) of different sizes were defined 
with masks and applied always at the same location of 
a sample. Since no significant difference was seen by 
choosing the 2, 4 or 6 mm mask, only the 6 mm mask 
results are presented. The solid content (bone + scaffold 
volume fraction) of the four material groups is shown in 
Fig. 10 according to the evaluated ROI and implantation 
Fig. 10. Solid content as a function of implantation time. 
The values at time zero represent the solid content (= 
(bone + ceramic)/total volume) of the scaffold before 
implantation. n = 18 for data at time point 0 and n = 4 - 6 
for data at 2, 4 and 8 weeks, depending on the amount 
of missing samples. In two conditions (Mg, 2 weeks 
and MG, 4 weeks), two many samples were missing.
Fig. 11. Comparison of solid content ((bone + ceramic)/
total volume) before implantation and after 8 weeks 
implantation in vivo (dark colour) for the four tested 
scaffold types. The post-implantation results were 
evaluated with a 6 mm mask. The evolution of the solid 
content was significantly different when comparing 
samples with low and high microporosity (see the 
directions of the arrows for mg and Mg on one side, 
and Mg and MG on the other side).
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time. Even though differences between groups were not 
significant, the highly microporous samples had the lowest 
solid content.
 The solid content before implantation was compared 
with the solid content (scaffold + bone) after 8 weeks 
in vivo (Fig. 11). Univariate ANOVA did not show any 
statistically significant influence of time, but a significant 
influence of the material as well as time and material 
combined: whereas the solid content increased during 
implantation for samples with low microporosity (mg 
and mG), the opposite was found for highly microporous 
samples.
Discussion
Design
The aim of this study was to decipher the link between 
grain size, microporosity, and in vivo behaviour of β-TCP 
scaffolds. For that purpose, an attempt was made to design 
scaffolds according to a factorial design of experiments 
where the two investigated factors would be microporosity 
(low ↔ “m”/high ↔ “M”) and grain size (small ↔ “g”, 
large ↔ “G”). Ideally, the samples were meant to only 
vary according to these two parameters, i.e. both the total 
porosity and the mean macropore size were meant to be 
kept constant. To control the architecture, the idea was 
to play with two parameters affecting ceramic sintering: 
time and temperature. It is indeed known that ceramic 
densification and grain growth are two distinct phenomena 
(Chen and Chen, 1996; Chen and Chen, 1997; Chen and 
Wang, 2000). Whereas grain growth is favoured at high 
temperature, densification is mostly a function of the 
ceramic density and grain size. Therefore, full densification 
can be achieved by two-step sintering: in a first stage, the 
ceramic is heated up at high temperature to rapidly reach 
a density superior to ≈ 75 %, and then the temperature 
is reduced by a few hundred degrees to fully densify the 
ceramic without concomitant grain growth (Chen and 
Wang, 2000). For example, Mazaheri et al. sintered 98 % 
dense hydroxyapatite 60 s at 900 °C and 2 h at 800 °C and 
were able to reduce the grain size from 1.7 μm to 190 nm 
(Mazaheri et al., 2009).
 In the present study, numerous samples were 
synthesised to achieve the required compositions and 
architectures. Specifically, samples were prepared by one 
and two-step sintering, at heating rates ranging from 1 to 
5 °C/min, with dwell times ranging from 1 to 15 h, and 
with plateau values ranging from 600 to 1300 °C. During 
two-step sintering, the first plateau was either the highest in 
temperature to achieve high densification, or the lowest to 
achieve poor densification. The temperature of the second 
plateau was then selected to either coarsen the grains or 
keep the grains small. Results showed that it was not 
possible to play much with the two-step sintering (data 
not shown), perhaps because a high densification could 
not be achieved. Therefore, it was decided to add a fine 
combustible additive (wheat flour) into the α-TCP, PEG and 
stearic acid mixtures to create additional micropores. The 
success was limited because the wheat flour particles were 
fairly large, with peaks in the volume distribution close 
to 30 μm and 100 μm. Also, it appeared that a change of 
microstructure affected the ability of α-TCP raw material 
to convert to β-TCP during sintering. Specifically, mG 
samples contained 16 % α-TCP despite the fact that these 
samples were submitted to an additional thermal treatment 
Fig. 12. Histomorphometrical results obtained in different studies by the same team and with the same sheep model 
(Nuss et al., 2006). Two results are reported: (a) ceramic content, and (b) bone content. The bone graft substitutes 
had various compositions (β-TCP, brushite, monetite, apatite, gypsum) and forms (scaffolds, cements). The various 
symbols were used: (Δ) Results of the present study with β-TCP scaffolds; (▲) β-TCP scaffolds varying in macropore 
size between 150 and 1200 μm (von Doernberg et al., 2006). (o) Results with four cements: gypsum, brushite without 
and with additional β-TCP granules, and apatite cement (= apatite CPC) (von Rechenberg et al., 2013). (●) Brushite 
cement (Theiss et al., 2005). (□) Brushite and apatite cement (Oberle et al., 2005). (■) Brushite and apatite cement 
(Apelt et al., 2004); (◊) β-TCP and monetite (unpublished results). For clarity reasons, no standard deviations were 
added. The dashed horizontal line corresponds to the mean fraction of bone that can be expected in a healthy animal.
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at a temperature (900 °C) at which α-TCP should readily 
convert to β-TCP (Chan et al., 2012). Therefore, at the end, 
the study design was not as good as expected, but there 
was still a clear difference of microporosity and grain size 
between the four scaffold types (Fig. 1, Fig. 2, Fig. 3, Fig. 
4, Table 2, Table 3). In addition, the groups with low/high 
microporosity and small/large granule size had similar 
values.
 Quantitatively, both grain size and microporosity 
varied threefold, which is at the lower end of what other 
authors have done in the past. For example, Gauthier et 
al. (Gauthier et al., 1999) varied their grain size from 
≈ 0.1-0.2 μm to ≈ 1 μm (Table 1). Hong et al. (Hong et al., 
2010) used a tenfold variation of grain size. Campion et 
al. (Campion et al., 2011) studied the effect of a twofold 
change of the strut (micro)porosity (23 to 46 %) on the in 
vivo performance of a silicon-substituted hydroxyapatite. 
For Coathup et al. (Coathup et al., 2012), the range was 
slightly larger (from 10 to 30 %). As a last example, Klein 
et al. (Klein et al., 1983; Klein et al., 1985; Klein et al., 
1986) varied the microporosity over a wider range (in one 
case from 2 to 60 %), but other architectural parameters 
were also affected such as the total porosity. Overall, it 
was believed that the architectural differences of the four 
groups tested in this study would be large enough to see 
significant differences in the selected animal model, in 
particular also because all 4 implant types belonged to a 
factorial design of experiment (large statistical power).
 Despite the care taken to control the composition of 
the different scaffolds, one group contained α-TCP (Table 
2) and minor changes of composition (in particular K and 
Mg contents) were observed due to the addition of flour 
(not shown here). In both cases, it is difficult to assess the 
potential effect on the biological response. Nevertheless, it 
is important to mention that α-TCP is expected to convert to 
calcium-deficient hydroxyapatite (CDHA) once implanted, 
and that CDHA has a solubility very close to that of β-TCP 
(Driessens and Verbeeck, 1990; Liu et al., 1999). In 
addition, there is evidence showing that the composition 
does not play much of a role in the present animal model 
and that α-TCP and β-TCP have similar in vivo behaviours 
(Wiltfang et al., 2002).
Scaffold characterisation
Considering the large number of structural factors that 
have been suggested to affect the in vivo response of 
resorbable scaffolds, it appeared important to perform a 
very thorough analysis of the scaffold architecture before 
implantation. This explains why five methods (weighing, 
materialography, Hg porosimetry, μCT, and N2 adsorption) 
were used to characterise the porous space (e.g., porosity 
and pore size) as well as the solid phase (e.g., grain size, 
specific surface area).
Total porosity
The two methods used to determine the total scaffold 
porosity had strong limitations: μCT can only detect pores 
larger than the resolution (10 μm here) and the type of 
Hg porosimetry used in the present study can only detect 
pores smaller than 100 μm. Therefore, the total porosity 
could only be measured accurately by weighing and 
materialography. The last two methods gave similar trends: 
the high microporosity samples had higher porosities than 
the low microporosity samples, and the highest porosities 
were measured for the Mg group (Table 2). Even though 
the correlation coefficient (r2) between these two methods 
was superior to 97 %, the porosity values obtained by 
weighing were significantly higher than those obtained by 
materialography. This could be related to an overestimation 
of the sample height and diameter used to calculate the 
sample volume, or to an underestimation of the sample 
weight due to surface irregularities. The results obtained 
by Hg porosimetry were very close to those obtained by 
weighing and materialography (Table 2). The correlation 
Table 4. Summary of the semi-quantitative cell response. Four groups were considered: (i) osteoclasts (defined 
arbitrarily here as multinucleated giant cells lying on a bone surface), (ii) multinucleated giant cells (MNGC; defined 
arbitrarily here as multinucleated giant cells lying on a ceramic or sitting away from a surface), (iii) macrophages, 
and (iv) lymphocytes and plasma cells (LP&P). Four zones were considered from the periphery (Z1) to the core (Z4).
2 weeks 4 weeks 8 weeks
Cell Zone mg Mg mG MG mg Mg mG MG mg Mg mG MG
Osteoclasts Z1 5.7 ± 2.7 5.8 ± 3.0 3.2 ± 1.9 2.8 ± 1.0 2.0 ± 1.3 3.0 ± 2.8 4.3 ± 4.1 4.8 ± 5.0 2.2 ± 0.4 3.0 ± 1.3 3.2 ± 1.7 2.0 ± 0.9
Z2 1.8 ± 1.7 1.4 ± 1.5 1.2 ± 1.2 0.5 ± 0.8 4.7 ± 4.0 3.6 ± 2.5 3.2 ± 1.6 1.8 ± 1.0 3.4 ± 1.7 2.7 ± 1.0 3.3 ± 1.5 2.5 ± 1.0
Z3 0.3 ± 0.8 0.0 ± 0.0 0.0 ± 0.0 0.2 ± 0.4 1.8 ± 1.0 2.0 ± 1.8 2.0 ± 1.1 2.5 ± 2.1 3.0 ± 0.7 2.2 ± 1.2 3.2 ± 3.1 2.2 ± 1.5
Z4 0.2 ± 0.4 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.7 ± 1.6 1.4 ± 2.1 1.2 ± 1.5 0.8 ± 1.0 3.2 ± 0.8 2.8 ± 1.8 2.3 ± 2.6 2.5 ± 2.1
MNGC Z1 4.7 ± 3.4 3.8 ± 4.6 1.8 ± 2.2 3.0 ± 3.1 1.5 ± 1.4 0.8 ± 1.3 0.8 ± 0.4 2.8 ± 3.4 0.2 ± 0.4 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Z2 5.7 ± 3.4 7.8 ± 5.2 2.2 ± 1.5 5.0 ± 4.7 6.7 ± 7.4 3.4 ± 4.5 4.7 ± 5.9 5.0 ± 5.3 0.0 ± 0.0 0.8 ± 1.6 0.0 ± 0.0 0.0 ± 0.0
Z3 3.5 ± 1.6 4.8 ± 2.6 1.7 ± 2.4 1.5 ± 1.2 4.5 ± 4.0 5.4 ± 4.4 2.5 ± 3.1 8.3 ± 5.6 0.2 ± 0.4 1.2 ± 2.0 0.8 ± 1.3 0.2 ± 0.4
Z4 3.3 ± 3.5 3.4 ± 2.1 0.7 ± 0.8 2.5 ± 3.8 3.8 ± 5.1 7.2 ± 7.3 1.7 ± 1.4 13.3 ± 12.0 0.2 ± 0.4 1.3 ± 2.3 0.7 ± 0.8 0.2 ± 0.4
Macrophages Z1 5.8 ± 3.4 9.0 ± 5.3 4.2 ± 0.8 8.0 ± 4.4 6.2 ± 3.3 3.6 ± 2.7 4.2 ± 3.3 5.0 ± 2.1 0.4 ± 0.5 0.3 ± 0.8 0.8 ± 0.8 1.2 ± 1.8
Z2 6.7 ± 8.5 9.6 ± 10.4 6.2 ± 2.0 4.5 ± 1.6 10.2 ± 4.8 5.0 ± 3.2 7.3 ± 6.9 6.3 ± 4.0 2.8 ± 2.3 2.5 ± 2.8 4.3 ± 4.7 1.0 ± 1.1
Z3 3.7 ± 1.2 9.8 ± 8.7 5.0 ± 1.4 5.8 ± 2.3 8.3 ± 3.1 6.4 ± 5.2 4.2 ± 4.2 5.3 ± 2.1 7.6 ± 8.6 3.2 ± 2.9 7.8 ± 11.4 3.3 ± 3.7
Z4 4.2 ± 2.2 6.6 ± 2.7 5.2 ± 2.6 4.8 ± 1.9 8.5 ± 7.0 6.6 ± 4.8 5.3 ± 2.2 7.5 ± 2.6 6.0 ± 3.7 5.2 ± 4.8 6.5 ± 7.3 4.2 ± 7.9
LP&P cells Z1 72.0 ± 165.6 10.6 ± 15.2 12.0 ± 21.8 13.7 ± 14.9 22.0 ± 38.7 17.8 ± 37.6 3.5 ± 3.2 2.5 ± 5.0 1.8 ± 3.0 0.7 ± 1.6 3.8 ± 5.3 1.0 ± 2.5
Z2 3.5 ± 7.2 8.8 ± 13.0 13.3 ± 13.6 8.5 ± 7.6 4.3 ± 4.8 4.6 ± 7.6 5.5 ± 8.1 17.5 ± 35.0 0.6 ± 1.3 1.7 ± 2.7 2.7 ± 2.3 1.7 ± 2.1
Z3 2.7 ± 4.5 8.8 ± 11.1 10.5 ± 7.2 9.5 ± 8.8 2.2 ± 4.0 13.6 ± 19.1 5.8 ± 9.8 0.5 ± 1.0 0.4 ± 0.9 3.8 ± 4.9 5.2 ± 5.0 3.2 ± 4.7
Z4 3.7 ± 5.0 9.4 ± 11.0 3.2 ± 3.8 5.8 ± 6.3 0.3 ± 0.8 8.2 ± 10.6 9.8 ± 13.6 2.3 ± 2.6 0.6 ± 1.3 4.8 ± 6.0 13.8 ± 18.7 6.5 ± 8.4
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coefficient was superior to 94 % when comparing Hg 
porosimetry results with weighing and materialography 
results. This high correlation is surprising because with 
the method settings selected for this study, Hg porosimetry 
only detected pores smaller than 100 μm, which suggest 
that most macropores were only accessible from the 
block outer surface through pores smaller than 100 μm. 
Therefore, it can be concluded that the total porosity of 
all groups was in the range of 75 -83 %. These values are 
similar to values previously reported in the literature for 
β-TCP bone graft substitutes (Walsh et al., 2003; Bohner 
et al., 2005; Bai et al., 2010; Feng et al., 2011).
Macroporosity
In the medical field, macropores are defined as pores large 
enough to allow bone ingrowth. The exact size is still 
matter of debate, but most agree that the value should be 
close to 50 μm (Lu et al., 1999; Karageorgiou and Kaplan, 
2005; Bohner et al., 2011; Chan et al., 2012). Therefore, 
a threshold value of 50 μm was used in the two methods 
allowing the determination of the pore size distribution, 
namely μCT and Hg porosimetry. The results showed that 
these two methods gave very different results, in particular 
for the small grain samples (mg and Mg): Hg porosimetry 
gave macroporosity values of 11 ± 3 % and 22 ± 10 % 
for samples mg and Mg, respectively, whereas these 
values were 54 ± 2 % and 50 ± 3 % using μCT (Table 2). 
However, there is a fundamental difference between both 
methods. When a given macropore is inside the scaffold, 
which is the case for the majority of the macropores (Fig. 
3), Hg porosimetry attributes a size, which corresponds 
to the diameter of the smallest interconnection leading 
to this macropore. The pore is then referred to be an ink-
bottle pore (Van Garderen et al., 2012). To determine the 
ink-bottle porosity, multicycle Hg intrusion was used. The 
values measured for the four scaffold types were very close 
to the total porosity, suggesting that most of the pores have 
a ink-bottle shape, which is not surprising when looking 
at the SEM images (Fig. 1-3).
 Beside μCT and Hg porosimetry, materialography was 
also used to assess the macroporosity. However, since it 
is not possible to determine precisely the pore size based 
on 2D images, macroporosity could only be estimated as 
the surface area of “large pores”, i.e. all pores that could 
be clearly defined in Fig. 1. Whereas such a definition was 
fairly easy to apply for mg and mG samples, it became 
much more difficult for the scaffolds produced with wheat 
flour (Mg) and particularly for those produced with wheat 
flour and large grains (MG; Fig. 1). This may explain why 
the latter value (48 ± 7 %) was quite low compared to the 
other values (all between 61 ± 4 and 65 ± 4 %; Table 2). In 
general, the values obtained by materialography were close 
to the values obtained by μCT (between 50 ± 3 % for Mg 
and MG, and 56 ± 2 % for mG). So, it can be stated that 
the macroporosity of four scaffold types was in a similar 
range (50-65 %), and that most of the macropores in small 
grain samples were not accessible through 50 μm large 
channels but through micropores, as indicated by the low 
macroporosity values measured by Hg porosimetry for 
these samples (11 ± 3 % for mg samples, and 22 ± 10 % 
for Mg samples; Table 2).
Macropore size
The mean macropore size could not be quantified accurately 
because of the limitations of the various characterisation 
methods. However, since pores smaller than the voxel size 
(10 μm) cannot be detected by μCT, the mean pore sizes 
determined by μCT can be considered to give an estimate 
of the mean macropore size. The values were comprised 
between 122 ± 2 μm (MG group) and 169 ± 10 μm (mg 
group) (Table 3). These values are in agreement with the 
SEM images (Fig 1).
 The determination of the link between macropore size 
and in vivo response of a scaffold has been the subject of 
intensive research. In their review article, Karageorgiou 
and Kaplan (Karageorgiou and Kaplan, 2005) came to the 
conclusion that macropores should be larger than 100 μm, 
most preferably larger than 300 μm to enhance “new 
bone formation and the formation of capillaries”. They 
also mentioned the need to have pore interconnections, 
particularly with a diameter larger than 100 μm. Here, 
the mean macropore sizes were at the lower end of the 
preferred range and the number of interconnections was 
limited. However, all four investigated scaffolds fulfilled 
their bone substitution function, i.e. were resorbed and 
replaced by new bone. In addition, bone was also found in 
the micropores of all four scaffold types (Fig. 7), suggesting 
that the walls of non-interconnected macropores could still 
be invaded by bone.
Microporosity
Three methods were used to assess the sample microporosity: 
materialography, Hg porosimetry, and μCT. Unfortunately, 
each of these methods has limitations. For example, pores 
smaller than the voxel size (10 μm) cannot be detected by 
μCT. Furthermore, Hg porosimetry consider ink-bottle 
macropores as micropores if the neck size is in the micro 
range. Finally, materialography can only give an estimate 
of the pore cross-sections. However, each of the three 
methods revealed a significantly higher microporosity 
for scaffolds designed to have a high microporosity (i.e., 
samples Mg and MG) (Table 2, Fig. 3, Fig. 4). Looking 
at materialography and μCT results, this difference was 
roughly twofold.
 Most in vivo studies devoted to β-TCP scaffolds do 
not report the amount and/or size of micropores (Klein 
et al., 1983; Klein et al., 1985; Klein et al., 1986; Walsh 
et al., 2003; Bohner et al., 2005; Bai et al., 2010; Feng 
et al., 2011), making comparisons difficult. Nevertheless, 
Yuan et al. (Yuan et al., 2010) studied microporous 
calcium phosphate granules containing between 3 and 
49 % microporosity (as determined by SEM image 
analysis). Here, the porosity of the microporous regions, 
as determined by materialography, was comprised between 
21 and 56 % (Table 2). Yuan et al. (Yuan et al., 2010) did 
not measure the micropore and grain size but the values 
that can be inferred from their SEM images are in a range 
(1-10 μm) close to those of scaffolds mg to MG (Table 
3). In another study, Bohner et al. (Bohner et al., 2005) 
considered macroporous scaffolds containing about 20 % 
microporosity. Again, these values are similar to those 
reported here (10 to 30 %; Table 2).
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 To conclude this section on scaffold characterisation, 
it can be stated that the four scaffold architectures tested 
here had morphological features similar to those of many 
scaffolds presented in the literature. Unfortunately, it 
was not possible to reach a perfect control of the scaffold 
architecture. Finally, the differences observed between the 
different characterisation methods underline the difficulty 
to quantify architectural features (Bohner et al., 2011).
In vivo results
In the scientific literature, few studies have addressed the 
effect of grain size and microporosity, in particular on 
resorbable materials (Table 1). Gauthier et al. (Gauthier 
et al., 1999) found a fourfold increase of resorption rate of 
BCP scaffolds with a five to ten fold increase of grain size. 
However, they attributed this increase to the presence of 
calcium oxide impurities and a “more intimate mixture and 
stable ultrastructure”. No difference of bone formation was 
noticed. Hong et al. (Hong et al., 2010) observed a 10-20 % 
increase in bone formation with a nine fold increase of 
grain size. Klein et al. (Klein et al., 1983; Klein et al., 1984; 
Klein et al., 1985; Klein et al., 1986) performed several 
studies to investigate the effect of microporosity on the in 
vivo behaviour of β-TCP scaffolds. They concluded that 
a higher microporosity increased the resorption rate, but 
results were mostly qualitative. More recently, Yokozeki 
et al. (Yokozeki et al., 1998) showed that the addition of 
micropores into a β-TCP scaffold increased resorption, 
but no XRD data showing conclusively the nature of the 
calcium phosphate was presented despite the unusually 
slow sample resorption (for β-TCP). Furthermore, no 
explanation was provided to explain the high SSA value 
of the dense samples (2 m2/g; current study: between 
0.37 ± 0.02 to 0.79 ± 0.08 m2/g; Table 3). This survey shows 
that the results presented in the literature are sometimes 
contradictory.
 By conducting the present systematic study, it was 
hoped that clearer conclusions could be drawn regarding 
the effect of microporosity and grain size, but hardly any 
difference could be detected between the four sample 
types. One may argue that the animal model used here is 
not sensitive enough to test osteoconduction. However, in 
this model, empty defects are filled with fat and fibrous 
tissue and only ca. 20 % bone forms at the defect edges 
(Nuss et al., 2006). Since the defects are not subjected to 
mechanical loading, the formation of fibrous tissue cannot 
be attributed to a mechanical stability. Combining these two 
observations reveal that the presence of a bone substitute 
in the defect is essential for its regeneration and one may 
talk about “critical-size defects”. Obviously, other models 
could have been considered, such as maxillofacial onlay 
models or spine postero-lateral fusion models. It is possible 
that the conclusions could have been different. However, 
our goal was to test bone substitutes in a model that is 
relevant for orthopaedic applications. Also, it allowed 
direct comparison between results of different in vivo 
studies. Importantly, there is to our knowledge no scientific 
publication linking animal model (specie, location) and 
study outcome. It is true that some models seem to be very 
sensitive (e.g., ectopic models (Yuan et al., 2010)), but 
there are few data showing their relevance for orthotopic 
locations.
 Regarding the absence of significant differences 
between tested scaffolds, one may also argue that the three-
fold change of microporosity and grain size was too limited 
to produce significant results. However, Campion et al. 
(Campion et al., 2011) (twofold change of microporosity) 
and Coathup et al. (Coathup et al., 2012) (three-fold change 
of microporosity) observed highly significant effects. 
Moreover, even though the number of experimental repeats 
(n = 6) was below the number generally recommended in 
standardised animal tests (n = 8), the experiments were 
performed according to a factorial design of experiment. 
Therefore, the standard deviation of each experimental 
group was not only calculated from the results of 6 
experiments, but the results of 72 experiments. As such, 
the statistical power of the present study was much higher 
than with n = 8. The second explanation for the absence 
of significant differences is that the biological response 
was not affected by the physical changes of the scaffolds. 
Results presented in the literature suggest indeed that the 
biological response of bone substitutes has a low sensitivity 
to physico-chemical changes. For example, many materials 
have been successful as bone substitute, despite a broad 
range of solubility and resorption mechanism. Focusing 
on architecture, Lu et al. (Lu et al., 1999) explained this 
low sensitivity to the geometric changes occurring during 
resorption. Okuda et al. (Okuda et al., 2007) proposed that 
“the bioresorbability of the bone substitute (…) affects 
the metabolism of the subsequently formed bone tissue”. 
Metsger (Metsger et al., 1993) noticed that “there appears 
to be a critical time during which resorption and bone 
ingrowth are accelerated at a faster rate”. Later, this author 
wrote that “there is a trend for implants of both pore size 
distributions to increase simultaneously in volume porosity 
and bone ingrowth”. Cancedda’s group (Mastrogiacomo 
et al., 2007; Papadimitropoulos et al., 2007) went a step 
further and postulated that there is a coupling between 
ceramic resorption and bone formation. This idea was then 
used by Bashoor-Zadeh et al. (Bashoor-Zadeh et al., 2011) 
to explain why the resorption rate of β-TCP scaffolds did 
not vary despite large changes of macropore size (from 150 
to 1200 μm). The coupling between scaffold resorption and 
bone formation could explain the strong correlation seen 
in this study between ceramic content and bone volume 
(r2 = 0.85; Fig. 8d).
 To explore the coupling mechanism between resorption, 
bone formation and scaffold in more detail, all results 
obtained with the present animal model and resorbable 
bone graft substitutes varying in composition (monetite, 
brushite, β-TCP, apatite, gypsum) and formulations 
(scaffolds, cements) were computed and plotted together 
(Fig 12). The main observation is that all resorption and 
bone formation results are fairly similar, despite changes in 
solubility over several order of magnitudes (e.g., between 
gypsum and hydroxyapatite) and significant changes in 
architecture (from sub-microporous for apatite cements to 
macroporous). Indeed, the bone substitute fraction varied 
between 0 % and 70 % of the initial amount at two months 
(Fig. 12a), whereas the bone fraction varied between 20 
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and 50 % (Fig. 12b). This finding suggests that there is a 
very strong coupling between implant resorption and bone 
formation. This could be related to the fact that calcium 
and phosphate ions, which are temporarily released during 
calcium phosphate resorption via dissolution (Koerten and 
van der Meulen, 1999), are known to regulate bone cell 
metabolism (Zaidi et al., 1989; Meleti et al., 2000; Wu et 
al., 2003). In addition, there is evidence that phosphate 
ions can act as an osteoinductive substance (Habibovic et 
al., 2010). Summarising the results obtained with various 
calcium phosphate bone graft substitutes in the sheep 
model used in this study, it appears that the biological 
response of calcium phosphate bone graft substitutes is 
very moderately affected by their architecture and chemical 
composition. In Fig. 12, the only underperforming 
materials were poorly-resorbable dense materials such 
as apatite cements: their resorption rate was low, hence 
limiting bone formation. Nevertheless, the sheep model 
considered here is a so-called 5-wall defect in cancellous 
bone. Other conclusions might be drawn if the samples had 
been implanted in more open defects (Misch and Dietsh, 
1993). The latter defects are typically found in the dental 
field, where hydroxyapatite-based materials are still the 
most-used bone substitutes (which does not necessarily 
mean that they are the best materials). The conclusions 
drawn from this study cannot be generalised, but underline 
the need to consider critically the outcome of animal 
studies.
 A few years ago, Lan Levengood et al. (Lan Levengood 
et al., 2010) looked at the effect of micropores on the 
in vivo response of biphasic calcium phosphates. They 
observed extensive bone formation within the microporous 
space despite the fact that it is generally agreed that 
bone invasion requires pore interconnections of at least 
100 μm (Karageorgiou and Kaplan, 2005). These authors 
talked about “multiscale osteointegration” and “paradigm 
shift”. Their results can be related to the work done on 
microporous β-TCP “plugs” by Mayr et al. (Mayr et al., 
2007; Mayr et al., 2009; Bernstein et al., 2013; Mayr et al., 
2013) showing that micropores can be invaded by bone and 
that the plugs – despite the absence of macropores – can be 
rapidly resorbed and replaced by new bone. Other authors 
made similar observations (Hing et al., 2005; Hing et al., 
2007). Here, the presence of blue-stained tissues within the 
micropores of the four scaffolds support these observations.
 Logically, bone invasion into the microporous space 
should be a function of the size of the interconnections 
between micropores. Indeed, bone matrix deposition is 
the result of a cellular process, so the absence of cell 
invasion should preclude any bone formation in the 
microporous space. In a recent study, Polak et al. (Polak 
et al., 2013) studied the penetration depth of cells into a 
microporous ceramic and could relate the results to the 
size and stiffness of the tested cells. Interestingly, these 
authors showed that cells could invade micropores through 
pore interconnections smaller than their diameter. The 
importance of cell penetration could explain why there 
is, to our knowledge, no study reporting bone invasion 
into apatite cements, materials that are characterised by 
sub-µm to nm scale pore interconnections (Espanol et al., 
2009). In the present study, not only the microporosity 
but also the micropore size varied threefold. Two scaffold 
types contained sub-µm pore interconnections (Fig 2-4), 
well below bone-relevant cell sizes (4-12 μm; (Polak et 
al., 2013)). Nevertheless, blue-stained tissue invasion 
was observed in all 4 sample types (Fig. 7). Transmission 
electron microscopy images will have to be taken and other 
staining will have to be done to confirm the formation of 
mineralised collagen and cells in the microporous space.
Conclusion
Four types of β-TCP scaffolds were produced with the 
same macropore size (≈ 150 μm) and total porosity 
(≈ 80 %), but various microporosities (from 10 to 30 %) 
and grain sizes (from 1.3 to 3.4 μm). As a result, the four 
groups were considered to be part of a factorial design of 
experiments comprising two factors (microporosity and 
grain size) and two levels (low and high). The samples 
architecture was characterised according to different 
methods, such as geometrical density, materialography, 
Hg porosimetry, μCT, and nitrogen adsorption. The results 
demonstrated that the design was not perfect, but certainly 
sufficient to draw conclusions about the two investigated 
factors. Six samples of each group were implanted in a 
sheep model for 2, 4 and 8 weeks, leading to a total of 
72 samples. The histological, histomorphometrical, and 
μCT analysis revealed no difference of bone formation 
between the different groups. The only significant factor 
at p < 0.01 was an increase of resorption and fibrous tissue 
formation with an increase of microporosity between 4 
and 8 weeks implantation. Considering the three-fold 
difference in grain size and microporosity between the 
different scaffolds, these results suggest that the biological 
mechanisms controlling healing are highly regulated, and 
that the in vivo performance of scaffolds implanted in the 
present animal model are mostly limited by biology rather 
than scaffold design. This conclusion is supported by the 
results obtained in the same animal model but with non-
macroporous and macroporous scaffolds made of materials 
varying in solubility over several degrees of magnitude 
(from gypsum to apatite cement, via monetite scaffolds). 
Provided the material is not inert or readily soluble, ceramic 
resorption and bone formation occur always more or less at 
the same rate in this particular 5-wall sheep model defect, 
fairly independently of architecture and composition. The 
conclusions drawn from this study cannot be generalised, 
but underline the need to consider critically the outcome 
of animal studies. Also, the presence of blue-stained 
tissues within the micropores regions suggest that an in-
depth microstructural study has to be performed to better 
understand the mechanisms of ceramic resorption and bone 
formation in microporous β-TCP bone substitutes.
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